Indian ITC-HS · Section VI
Chapter 30
Pharmaceutical products
6 Headings47 Subheadings228 Tariff Items
Source: CBIC Part II Import Tariff, chapter-wise PDFs·Indian Customs Tariff — First Schedule (as on 30.06.2024, CBIC)
Section VI
PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES
Showing each item's best available FTA rate beside its MFN baseline.
Headings, subheadings & tariff items
|
30021100Omitted30021210For diphtheriaMFN 10%→0%30021220For tetanusMFN 10%→0%30021230For rabiesMFN 10%→0%30021240For snake venomMFN 10%→0%30021290OtherMFN 10%→0%30021300Immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleMFN 10%→0%30021400Immunological products, mixed, not put up in measured doses or in forms or packings for retail saleMFN 10%→0%30021500Immunological products, put up in measured doses or in forms or packings for retail sale (excluding yeasts) and similar products:MFN 10%→0%30024111- Cholera and typhoidMFN 10%→0%30024112- HepatitisMFN 10%→0%30024113- TetanusMFN 10%→0%30024114- PolioMFN 10%→0%30024115- TuberculosisMFN 10%→0%30024116- RabiesMFN 10%→0%30024117- Japanese encephalitisMFN 10%→0%30024118- Whopping cough (pertussis)MFN 10%→0%30024119- OtherMFN 10%→0%30024121- Diphtheria, pertussis and tetanus (DPT)MFN 10%→0%30024122- Diphtheria and tetanus (DT)MFN 10%→0%30024123- Measles, mumps and rubella (MMR)MFN 10%→0%30024124- Typhoid-paratyphoid (TAB)MFN 10%→0%30024125- Typhoid-paratyphoid-cholera (TABC)MFN 10%→0%30024129- OtherMFN 10%→0%30024200Vaccines for veterinary medicineMFN 10%→0%30024910Cultures of micro-organisms (excluding yeast)MFN 5%→0%30024920ToxinsMFN 10%→0%30024990OtherMFN 10%→0%30025100Cell therapy productsMFN 10%→0%30025900OtherMFN 10%→0%30029010Human bloodMFN 10%→0%30029020Animal blood prepared for therapeutic, prophylactic or diagnostic usesMFN 10%→0%30029090OtherMFN 10%→0%
30031000Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivativesMFN 10%→0%30032000Other, containing antibiotics of heading 2937:MFN 10%→0%30033100Containing insulinMFN 10%→0%30033900Other thereof:MFN 10%→0%30034100Containing ephedrine or its saltsMFN 10%→0%30034200Containing pseudoephedrine (INN) or its saltsMFN 10%→0%30034300Containing norephedrine or its saltsMFN 10%→0%30034900OtherMFN 10%→0%30036000Other, containing antimalarial active principles described in Sub-heading Note 2 to this ChapterMFN 10%→0%30039011- Of Ayurvedic systemMFN 10%→0%30039012- Of Unani systemMFN 10%→0%30039013- Of Siddha systemMFN 10%→0%30039014- Of Homoeopathic systemMFN 10%→0%30039015- Of Bio-chemic systemMFN 10%→0%30039021- Menthol crystalsMFN 10%→0%30039022- Milk of magnesia origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel :MFN 10%→0%30039031- Bovine albumin and drugs of animal originMFN 10%→0%30039032- Merbromine national formulary XII (mercurochrome)MFN 10%→0%30039033- Calcium sennosideMFN 10%→0%30039034- Anaesthetic agents used in human or veterinary medicine or surgery kg. 10% 10%MFN 10%→0%30039035- Aluminium hydroxide gelMFN 10%→0%30039036- KetamineMFN 10%→0%30039090OtherMFN 10%→0%
30041010PenicillinsMFN 10%→0%30041020AmpicillinMFN 10%→0%30041030AmoxycillinMFN 10%→0%30041040BecampicillinMFN 10%→0%30041050CloxacillinMFN 10%→0%30041060Ampicillin and cloxacillin combinationsMFN 10%→0%30041070StreptomycinMFN 10%→0%30041090OtherMFN 10%→0%30042011- CefazolinMFN 10%→0%30042012- CephalexinMFN 10%→0%30042013- CiprofloxacinMFN 10%→0%30042014- CefoxitinMFN 10%→0%30042019- OtherMFN 10%→0%30042020Sulfonamides and cotrimoxazoleMFN 10%→0%30042031- NorfloxacinMFN 10%→0%30042032- Nalidixic acidMFN 10%→0%30042033- CiprofloxacinMFN 10%→0%30042034- OfloxacinMFN 10%→0%30042039- OtherMFN 10%→0%30042041- ChlortetracyclineMFN 10%→0%30042042- OxytetracyclineMFN 10%→0%30042049- OtherMFN 10%→0%30042050ChloramphenicolMFN 10%→0%30042061- ErythromycinMFN 10%→0%30042062- RoxithromycinMFN 10%→0%30042063- ClarithromycinMFN 10%→0%30042064- AzithromycinMFN 10%→0%30042069- OtherMFN 10%→0%30042070- CefadroxilMFN 10%→0%30042091- IsoniazidMFN 10%→0%30042092- RifampicinMFN 10%→0%30042093- PyrazinamideMFN 10%→0%30042094- EthambutolMFN 10%→0%30042095- ClindamycinMFN 10%→0%30042096- VancomycinMFN 10%→0%30042097- Polymyxin B and colistinMFN 10%→0%30042099- Other of heading 2937:MFN 10%→0%30043110Insulin injectionMFN 10%→0%30043190OtherMFN 10%→0%30043200Containing corticosteroid hormones, their derivatives or structural analoguesMFN 10%→0%30043911- Pituitary hormonesMFN 10%→0%30043912- PrednisoloneMFN 10%→0%30043913- DexamethasoneMFN 10%→0%30043914- DanazolMFN 10%→0%30043919- Other progestogen and oestogen group hormonesMFN 10%→0%30043921- GonadotrophinsMFN 10%→0%30043922- Luteinising hormoneMFN 10%→0%30043990Other thereof:MFN 10%→0%30044100Containing ephedrine or its saltsMFN 10%→0%30044200Containing pseudoephedrine (INN) or its saltsMFN 10%→0%30044300Containing norephedrine or its saltsMFN 10%→0%30044910Atropin and salts thereofMFN 10%→0%30044920Caffein and salts thereofMFN 10%→0%30044930Codeine and derivatives, with or without ephidrine hydrochlorideMFN 10%→0%30044940Ergot preparations, ergotamine and salts thereofMFN 10%→0%30044950Papavarine hydrochlorideMFN 10%→0%30044960Bromohexin and solbutamolMFN 10%→0%30044970Theophylline and salts thereofMFN 10%→0%30044990OtherMFN 10%→0%30045010Heamatinics and erythropoietin preparationsMFN 10%→0%30045020Preparations of minerals and their supplementsMFN 10%→0%30045031- Of vitamin AMFN 10%→0%30045032- Of vitamin B and B and salts thereof 1 2MFN 10%→0%30045033- Of vitamin B 9MFN 10%→0%30045034- Of vitamin B 12MFN 10%→0%30045035- Of vitamin CMFN 10%→0%30045036- Of vitamin DMFN 10%→0%30045037- Of vitamin EMFN 10%→0%30045039- OtherMFN 10%→0%30045090OtherMFN 10%→0%30046000Other, containing antimalarial active principles described in Sub-heading Note 2 to this ChapterMFN 10%→0%30049011- Of Ayurvedic systemMFN 10%→0%30049012- Of Unani systemMFN 10%→0%30049013- Of Siddha systemMFN 10%→0%30049014- Of Homoeopathic systemMFN 10%→0%30049015- Of Bio-chemic system antiprotozal drugs; antifungal drugs :MFN 10%→0%30049021- Anthelmintics and preparations thereofMFN 10%→0%30049022- MetronidazoleMFN 10%→0%30049023- TinidazoleMFN 10%→0%30049024- SecnidazoleMFN 10%→0%30049025- Diluxamide furoateMFN 10%→0%30049026- Sodium stibogluconateMFN 10%→0%30049027- PentamidineMFN 10%→0%30049029- Other antiulcer drugs; antiemitics and other gastrointestinal drugs :MFN 10%→0%30049031- Promethazine, chlorpheniramine, astemizole and ceteirizineMFN 10%→0%30049032- Sodium bicarbonate, magnesium hydroxide (milk of magnesia), magnesium carbonate, magnesium trisilicate, aluminium hydroxide gel, magaldarate and combinations thereofMFN 10%→0%30049033- Cimetidine, rantidine, nizatidine and roxatidineMFN 10%→0%30049034- Omeprazole and lansoprazoleMFN 10%→0%30049035- Dicyclomine, metoclopramide and dexame thasone and ondansetronMFN 10%→0%30049036- Chenodiol and ursodiolMFN 10%→0%30049039- OtherMFN 10%→0%30049041- CyclophosphamideMFN 10%→0%30049042- Methotrexate, 5-fluorouracil(5-FU) and ftorafurMFN 10%→0%30049043- Bincristine and vinblastineMFN 10%→0%30049044- Paclitaxel and docetaxelMFN 10%→0%30049045- EtoposideMFN 10%→0%30049046- Actinomycin D Dactinomycin and doxorubicinMFN 10%→0%30049047- L-Asparaginase, cisplatin and carboplatinMFN 10%→0%30049048- TamoxifenMFN 10%→0%30049049- Other antimalarial drugs :MFN 10%→0%30049051- IsoniazidMFN 10%→0%30049052- RifampicinMFN 10%→0%30049053- Pyrazinamide and ethambutolMFN 10%→0%30049054- StreptomycinMFN 10%→0%30049055- Dapsone (DDS), acedapsone (DADDS), solopsone and clofazimineMFN 10%→0%30049056- Chloroquine, amodiaquine, mefloquine, quinine, chloroguamide, pyrimethamineMFN 10%→0%30049057- Other antitubercular drugsMFN 10%→0%30049058- Other antileprotic drugsMFN 10%→0%30049059- Other antimalarial drugs and antipyratic drugs :MFN 10%→0%30049061- Analgin with or without other compounds such as paracetamol kg. 10% 10%MFN 10%→0%30049062- Acetyl salicylic acid (aspirin) and formulations thereofMFN 10%→0%30049063- Ibuprofen with or without paracetamol or other compounds kg. 10% 10%MFN 10%→0%30049064- Oxyphen butazone, phenyl butazone and formulations thereof kg. 10% 10%MFN 10%→0%30049065- IndomethacinMFN 10%→0%30049066- Mephenamic acid, dactofenac sodium, piroxicam, tenoxicam and meloxicamMFN 10%→0%30049067- Ketorolac, nimesulide, nabumetone and nefopamMFN 10%→0%30049069- OtherMFN 10%→0%30049071- Captopril, enalapril, lisinopril, perindopril and ramiprilMFN 10%→0%30049072- Verapamil, nifedipine, amlodipine and lacidipineMFN 10%→0%30049073- LosartanMFN 10%→0%30049074- Propranolol, metoprolol, atenolol and labetalolMFN 10%→0%30049075- Prazosin, terazosin, phentolamine and phenoxybenzamine kg. 10% 10%MFN 10%→0%30049076- Clonidine, methyldopaMFN 10%→0%30049077- Hydralazine, minoxidil and diazoxideMFN 10%→0%30049079- Other elsewhere specified or included, preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; oral rehydration salts; antibacterial formulations not elsewhere specified or included, sedatives and tranquilizers :MFN 10%→0%30049081- Phenobarbitone, mephobarbitone, primidone, phenytoin, carbamazepine, ethosuccimide, valporic acid (sodium valporate), diazepam, lamotrigine, gabapentin, bigabatrin, phenacemide, trimethadione and acetazolamideMFN 10%→0%30049082- Other antiepileptic drugsMFN 10%→0%30049083- Sulpha drugs not elsewhere specified or includedMFN 10%→0%30049084- Preparations of enzymesMFN 10%→0%30049085- Veterinary medicinal preparations, not for human use, not elsewhere specified or includedMFN 10%→0%30049086- Oral rehydration saltsMFN 10%→0%30049087- Antibacterial formulations, not elsewhere specified or included kg. 10% 10%MFN 10%→0%30049088- SedativesMFN 10%→0%30049089- TranquilizersMFN 10%→0%30049091- Salbutamol, terbutaline, ephedrine, salmeterol and methyl xanthimes kg. 10% 10%MFN 10%→0%30049092- Plasma expandersMFN 10%→0%30049093- Chloropheniramine maleate, with or without other compounds kg. 10% 10% (excluding steriods and alkaloids)MFN 10%→0%30049094- Theophylline, aminophylline and other broncho dilators kg. 10% 10%MFN 10%→0%30049095- Carcino-chemotherapeutic drugs not elsewhere specified or included kg. 10% 10%MFN 10%→0%30049096- KetamineMFN 10%→0%30049099- OtherMFN 10%→0%
30051010Adhesive guazeMFN 10%→0%30051020Adhesive tapeMFN 10%→0%30051090OtherMFN 10%→0%30059010Cotton wool, medicatedMFN 10%→0%30059020Poultice of kaolinMFN 10%→0%30059030Lint, medicatedMFN 10%→0%30059040BandagesMFN 10%→0%30059050Burn therapy dressing soaked in protective gelMFN 10%→0%30059060Micro pores surgical tapesMFN 10%→0%30059070Corn removers and callous removersMFN 10%→0%30059090OtherMFN 10%→0%
30061010Sterile, surgical catgut and similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for wound closureMFN 10%→0%30061020Sterile laminaria and sterile laminaria tents, sterile absorbable surgical or dental haemostatics, sterile surgical or dental adhesion barriers, whether or not absorbableMFN 10%→0%30062000Omitted30063000Opacifying preprations for X-ray examinations; diagnostic kg. 10% - reagents designed to be administered to the patientMFN 10%→0%30064000Dental cements and other dental fillings; bone reconstruction cementsMFN 10%→0%30065000First-aid boxes and kitsMFN 10%→0%30066010Based on hormonesMFN 0%30066020Based on other products of headingMFN 0%30066030Based on spermicidesMFN 0%30067000Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instrumentsMFN 10%→0%30069100Appliances identifiable for ostomy useMFN 10%→0%30069200Waste pharmaceuticals 10% -MFN 10%→0%30069300Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]MFN 10%→0%
All tariff codes in Chapter 30
Flat index of every 8-digit tariff item in this chapter, grouped by 4-digit heading.
3001GLANDS AND OTHER ORGANS FOR ORGANO- THERAPEUTIC USES, DRIED, WHETHER OR NOT POWDERED; EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANO- THERAPEUTIC USES; HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBSTANCES PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT ELSEWHERE SPECIFIED OR INCLUDED
3002HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICRO-ORGANISMS (EXCLUDING YEASTS) AND OTHER SIMILAR PRODUCTS; CELL CULTURES, WHETHER OR NOT MODIFIED; immunological products, whether or not modified or obtained by biotechnological processes:
- 30021100Omitted
- 30021210For diphtheria
- 30021220For tetanus
- 30021230For rabies
- 30021240For snake venom
- 30021290Other
- 30021300Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
- 30021400Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
- 30021500Immunological products, put up in measured doses or in forms or packings for retail sale (excluding yeasts) and similar products:
- 30024111- Cholera and typhoid
- 30024112- Hepatitis
- 30024113- Tetanus
- 30024114- Polio
- 30024115- Tuberculosis
- 30024116- Rabies
- 30024117- Japanese encephalitis
- 30024118- Whopping cough (pertussis)
- 30024119- Other
- 30024121- Diphtheria, pertussis and tetanus (DPT)
- 30024122- Diphtheria and tetanus (DT)
- 30024123- Measles, mumps and rubella (MMR)
- 30024124- Typhoid-paratyphoid (TAB)
- 30024125- Typhoid-paratyphoid-cholera (TABC)
- 30024129- Other
- 30024200Vaccines for veterinary medicine
- 30024910Cultures of micro-organisms (excluding yeast)
- 30024920Toxins
- 30024990Other
- 30025100Cell therapy products
- 30025900Other
- 30029010Human blood
- 30029020Animal blood prepared for therapeutic, prophylactic or diagnostic uses
- 30029090Other
3003MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF TWO OR MORE CONSTITUENTS WHICH HAVE BEEN MIXED TOGETHER FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE
- 30031000Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives
- 30032000Other, containing antibiotics of heading 2937:
- 30033100Containing insulin
- 30033900Other thereof:
- 30034100Containing ephedrine or its salts
- 30034200Containing pseudoephedrine (INN) or its salts
- 30034300Containing norephedrine or its salts
- 30034900Other
- 30036000Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter
- 30039011- Of Ayurvedic system
- 30039012- Of Unani system
- 30039013- Of Siddha system
- 30039014- Of Homoeopathic system
- 30039015- Of Bio-chemic system
- 30039021- Menthol crystals
- 30039022- Milk of magnesia origin, merbromine national formulary XII (mercurochrome), calcium sennoside, anaesthetic agents used in human or veterinary medicine or surgery, aluminium hydroxide gel :
- 30039031- Bovine albumin and drugs of animal origin
- 30039032- Merbromine national formulary XII (mercurochrome)
- 30039033- Calcium sennoside
- 30039034- Anaesthetic agents used in human or veterinary medicine or surgery kg. 10% 10%
- 30039035- Aluminium hydroxide gel
- 30039036- Ketamine
- 30039090Other
3004MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (INCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS FOR RETAIL SALE
- 30041010Penicillins
- 30041020Ampicillin
- 30041030Amoxycillin
- 30041040Becampicillin
- 30041050Cloxacillin
- 30041060Ampicillin and cloxacillin combinations
- 30041070Streptomycin
- 30041090Other
- 30042011- Cefazolin
- 30042012- Cephalexin
- 30042013- Ciprofloxacin
- 30042014- Cefoxitin
- 30042019- Other
- 30042020Sulfonamides and cotrimoxazole
- 30042031- Norfloxacin
- 30042032- Nalidixic acid
- 30042033- Ciprofloxacin
- 30042034- Ofloxacin
- 30042039- Other
- 30042041- Chlortetracycline
- 30042042- Oxytetracycline
- 30042049- Other
- 30042050Chloramphenicol
- 30042061- Erythromycin
- 30042062- Roxithromycin
- 30042063- Clarithromycin
- 30042064- Azithromycin
- 30042069- Other
- 30042070- Cefadroxil
- 30042091- Isoniazid
- 30042092- Rifampicin
- 30042093- Pyrazinamide
- 30042094- Ethambutol
- 30042095- Clindamycin
- 30042096- Vancomycin
- 30042097- Polymyxin B and colistin
- 30042099- Other of heading 2937:
- 30043110Insulin injection
- 30043190Other
- 30043200Containing corticosteroid hormones, their derivatives or structural analogues
- 30043911- Pituitary hormones
- 30043912- Prednisolone
- 30043913- Dexamethasone
- 30043914- Danazol
- 30043919- Other progestogen and oestogen group hormones
- 30043921- Gonadotrophins
- 30043922- Luteinising hormone
- 30043990Other thereof:
- 30044100Containing ephedrine or its salts
- 30044200Containing pseudoephedrine (INN) or its salts
- 30044300Containing norephedrine or its salts
- 30044910Atropin and salts thereof
- 30044920Caffein and salts thereof
- 30044930Codeine and derivatives, with or without ephidrine hydrochloride
- 30044940Ergot preparations, ergotamine and salts thereof
- 30044950Papavarine hydrochloride
- 30044960Bromohexin and solbutamol
- 30044970Theophylline and salts thereof
- 30044990Other
- 30045010Heamatinics and erythropoietin preparations
- 30045020Preparations of minerals and their supplements
- 30045031- Of vitamin A
- 30045032- Of vitamin B and B and salts thereof 1 2
- 30045033- Of vitamin B 9
- 30045034- Of vitamin B 12
- 30045035- Of vitamin C
- 30045036- Of vitamin D
- 30045037- Of vitamin E
- 30045039- Other
- 30045090Other
- 30046000Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter
- 30049011- Of Ayurvedic system
- 30049012- Of Unani system
- 30049013- Of Siddha system
- 30049014- Of Homoeopathic system
- 30049015- Of Bio-chemic system antiprotozal drugs; antifungal drugs :
- 30049021- Anthelmintics and preparations thereof
- 30049022- Metronidazole
- 30049023- Tinidazole
- 30049024- Secnidazole
- 30049025- Diluxamide furoate
- 30049026- Sodium stibogluconate
- 30049027- Pentamidine
- 30049029- Other antiulcer drugs; antiemitics and other gastrointestinal drugs :
- 30049031- Promethazine, chlorpheniramine, astemizole and ceteirizine
- 30049032- Sodium bicarbonate, magnesium hydroxide (milk of magnesia), magnesium carbonate, magnesium trisilicate, aluminium hydroxide gel, magaldarate and combinations thereof
- 30049033- Cimetidine, rantidine, nizatidine and roxatidine
- 30049034- Omeprazole and lansoprazole
- 30049035- Dicyclomine, metoclopramide and dexame thasone and ondansetron
- 30049036- Chenodiol and ursodiol
- 30049039- Other
- 30049041- Cyclophosphamide
- 30049042- Methotrexate, 5-fluorouracil(5-FU) and ftorafur
- 30049043- Bincristine and vinblastine
- 30049044- Paclitaxel and docetaxel
- 30049045- Etoposide
- 30049046- Actinomycin D Dactinomycin and doxorubicin
- 30049047- L-Asparaginase, cisplatin and carboplatin
- 30049048- Tamoxifen
- 30049049- Other antimalarial drugs :
- 30049051- Isoniazid
- 30049052- Rifampicin
- 30049053- Pyrazinamide and ethambutol
- 30049054- Streptomycin
- 30049055- Dapsone (DDS), acedapsone (DADDS), solopsone and clofazimine
- 30049056- Chloroquine, amodiaquine, mefloquine, quinine, chloroguamide, pyrimethamine
- 30049057- Other antitubercular drugs
- 30049058- Other antileprotic drugs
- 30049059- Other antimalarial drugs and antipyratic drugs :
- 30049061- Analgin with or without other compounds such as paracetamol kg. 10% 10%
- 30049062- Acetyl salicylic acid (aspirin) and formulations thereof
- 30049063- Ibuprofen with or without paracetamol or other compounds kg. 10% 10%
- 30049064- Oxyphen butazone, phenyl butazone and formulations thereof kg. 10% 10%
- 30049065- Indomethacin
- 30049066- Mephenamic acid, dactofenac sodium, piroxicam, tenoxicam and meloxicam
- 30049067- Ketorolac, nimesulide, nabumetone and nefopam
- 30049069- Other
- 30049071- Captopril, enalapril, lisinopril, perindopril and ramipril
- 30049072- Verapamil, nifedipine, amlodipine and lacidipine
- 30049073- Losartan
- 30049074- Propranolol, metoprolol, atenolol and labetalol
- 30049075- Prazosin, terazosin, phentolamine and phenoxybenzamine kg. 10% 10%
- 30049076- Clonidine, methyldopa
- 30049077- Hydralazine, minoxidil and diazoxide
- 30049079- Other elsewhere specified or included, preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; oral rehydration salts; antibacterial formulations not elsewhere specified or included, sedatives and tranquilizers :
- 30049081- Phenobarbitone, mephobarbitone, primidone, phenytoin, carbamazepine, ethosuccimide, valporic acid (sodium valporate), diazepam, lamotrigine, gabapentin, bigabatrin, phenacemide, trimethadione and acetazolamide
- 30049082- Other antiepileptic drugs
- 30049083- Sulpha drugs not elsewhere specified or included
- 30049084- Preparations of enzymes
- 30049085- Veterinary medicinal preparations, not for human use, not elsewhere specified or included
- 30049086- Oral rehydration salts
- 30049087- Antibacterial formulations, not elsewhere specified or included kg. 10% 10%
- 30049088- Sedatives
- 30049089- Tranquilizers
- 30049091- Salbutamol, terbutaline, ephedrine, salmeterol and methyl xanthimes kg. 10% 10%
- 30049092- Plasma expanders
- 30049093- Chloropheniramine maleate, with or without other compounds kg. 10% 10% (excluding steriods and alkaloids)
- 30049094- Theophylline, aminophylline and other broncho dilators kg. 10% 10%
- 30049095- Carcino-chemotherapeutic drugs not elsewhere specified or included kg. 10% 10%
- 30049096- Ketamine
- 30049099- Other
3005WADDING, GAUZE, BANDAGES AND SIMILAR ARTICLES (FOR EXAMPLE, DRESSINGS, ADHESIVE PLASTERS, POULTICES), IMPREGNATED OR COATED WITH PHARMACEUTICAL SUBSTANCES OR PUT UP IN FORMS OR PACKINGS FOR RETAIL SALE FOR MEDICAL, SURGICAL, DENTAL OR VETERINARY PURPOSES
3006PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER
- 30061010Sterile, surgical catgut and similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for wound closure
- 30061020Sterile laminaria and sterile laminaria tents, sterile absorbable surgical or dental haemostatics, sterile surgical or dental adhesion barriers, whether or not absorbable
- 30062000Omitted
- 30063000Opacifying preprations for X-ray examinations; diagnostic kg. 10% - reagents designed to be administered to the patient
- 30064000Dental cements and other dental fillings; bone reconstruction cements
- 30065000First-aid boxes and kits
- 30066010Based on hormones
- 30066020Based on other products of heading
- 30066030Based on spermicides
- 30067000Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments
- 30069100Appliances identifiable for ostomy use
- 30069200Waste pharmaceuticals 10% -
- 30069300Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]
Using HSN codes from Chapter 30
- Expand a heading to see every 6-digit subheading and 8-digit tariff item underneath. Unit of measure and standard duty are shown once per 4-digit heading.
- The standard duty shown is the Most-Favoured-Nation (MFN) rate from the Indian Customs Tariff.
- For GST filings, the 4-digit heading is usually sufficient; for customs declarations, the full 8-digit tariff item is required.
Related EximPe tools
Free, no signup — same trade-and-payments toolset your team uses to move money across borders.
SWIFT Code Finder
Verify SWIFT/BIC codes for global bank transfers. By country, city, or bank.
Open toolCurrency Converter
Live mid-market FX rates for 150+ currencies. Inbound INR conversions for exporters.
Open toolInvoice Generator
Build a cross-border invoice in minutes. Edit fields inline, export to PDF.
Open tool